Scalpa Inc., of Phoenix, Ariz. recalls
1 recall recorded since 2018, most recently on 14 January 2021. Status and classification are as published by the CPSC.
Recalls1
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 14 January 2021
- Reason
- The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning to young children.
- Remedy
- Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly notifying all known purchasers about the recall.
- Recall number
- 21719
- Scalpa Numb Maximum Strength Topical Anesthetic Cream
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.